Published in Ann Intern Med on February 01, 1994
Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis (RHEACT) | NCT05204784
The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol (2012) 1.32
Advances in the treatment of Raynaud's phenomenon. Vasc Health Risk Manag (2010) 1.19
Recent achievements in the management of Raynaud's phenomenon. Vasc Health Risk Manag (2010) 1.02
Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management. Int J Clin Rheumtol (2015) 0.95
Systemic sclerosis--challenges for clinical practice. Nat Rev Rheumatol (2012) 0.92
Practical approach to the therapy of systemic sclerosis. Z Rheumatol (2004) 0.91
Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis. Ann Rheum Dis (2007) 0.90
A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost. Clin Rheumatol (2009) 0.86
Pharmacotherapy of systemic sclerosis. Expert Opin Pharmacother (2010) 0.86
Registry evaluation of digital ulcers in systemic sclerosis. Int J Rheumatol (2010) 0.83
Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis. Clin Rheumatol (2007) 0.83
Connective tissue ulcers. J Tissue Viability (2013) 0.81
Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations. Indian J Dermatol (2013) 0.81
Severe Raynaud's phenomenon-A streamlined approach to acute management. Int J Surg Case Rep (2011) 0.81
Iloprost modulates the immune response in systemic sclerosis. BMC Immunol (2010) 0.80
Digital ischemia in scleroderma spectrum of diseases. Int J Rheumatol (2010) 0.80
Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon. Dig Dis Sci (1998) 0.79
Targeted therapy for systemic sclerosis: how close are we? Nat Rev Rheumatol (2010) 0.78
Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study. Eur J Clin Pharmacol (2006) 0.78
Digital ischemic loss in systemic sclerosis. Int J Rheumatol (2010) 0.78
Effects of alprostadil and iloprost on renal, lung, and skeletal muscle injury following hindlimb ischemia-reperfusion injury in rats. Drug Des Devel Ther (2016) 0.77
Large leg ulcers due to autoimmune diseases. Med Sci Monit (2011) 0.77
[Evidence-based therapy of Raynaud's syndrome]. Z Rheumatol (2006) 0.76
Raynaud's phenomenon (secondary). BMJ Clin Evid (2008) 0.76
Possible anti-metastatic effect of iloprost in a patient with systemic sclerosis with lung cancer: a case study. Rheumatol Int (2011) 0.76
Long-term clinical stabilization of scleroderma patients treated with a chronic and intensive IV iloprost regimen. Rheumatol Int (2016) 0.75
User preference for a portable syringe pump for iloprost infusion. Patient Relat Outcome Meas (2015) 0.75
The Application of Fluorescence Optical Imaging in Systemic Sclerosis. Biomed Res Int (2015) 0.75
Optimal management of digital ulcers in systemic sclerosis. Ther Clin Risk Manag (2015) 0.75
Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms. Front Pharmacol (2016) 0.75
Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion. Arthritis Res Ther (2013) 0.75
Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin. Eur J Med Res (2014) 0.75
Long-term evaluation of lung function in patients affected by scleroderma treated with cyclic iloprost infusions. Rheumatol Int (2004) 0.75
Raynaud's phenomenon and vitamin D. Rheumatol Int (2012) 0.75
A case of diffuse systemic sclerosis treated with a 28-day infusion of iloprost. Clin Rheumatol (1997) 0.75
A protein interaction map of Drosophila melanogaster. Science (2003) 20.06
An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med (1992) 18.11
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 16.45
Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs. Cell (1979) 12.83
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum (1998) 12.36
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell (1982) 9.27
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J (2001) 8.90
Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue. Virology (1978) 8.28
GPs in principle but not in practice: a study of vocationally trained doctors not currently working as principals. BMJ (1995) 8.09
A psychomotor stimulant theory of addiction. Psychol Rev (1987) 6.42
A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health (1980) 6.29
Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest (1999) 6.13
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol (1997) 6.10
Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J (1996) 6.08
Criteria for the classification of early systemic sclerosis. J Rheumatol (2001) 5.39
Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med (1992) 5.21
Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature (2001) 5.14
The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med A (1981) 5.02
Influence of substrate wettability on the attachment of marine bacteria to various surfaces. Appl Microbiol (1975) 4.70
Host-range mutants of adenovirus type 5 defective for growth in HeLa cells. Virology (1977) 4.40
Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis (1992) 4.19
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol (1995) 4.11
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med (2000) 4.07
Change in use of asthma as a diagnostic label for wheezing illness in schoolchildren. BMJ (1989) 3.80
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J Virol (1997) 3.79
The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol (1997) 3.77
Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest (2000) 3.75
The influence of dominance rank on the reproductive success of female chimpanzees. Science (1997) 3.74
Defective transforming capacity of adenovirus type 5 host-range mutants. Virology (1978) 3.52
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
Physical mapping of temperature-sensitive mutations of adenoviruses. Cold Spring Harb Symp Quant Biol (1975) 3.42
The minimal important difference of exercise tests in severe COPD. Eur Respir J (2010) 3.27
Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1994) 3.24
Addiction rare in patients treated with narcotics. N Engl J Med (1980) 3.20
Cell-cycle arrest versus cell death in cancer therapy. Nat Med (1997) 3.18
Generic inhalers for asthma. BMJ (1994) 3.09
A multirater validation study to assess the reliability of acne lesion counting. J Am Acad Dermatol (1996) 3.09
Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription. Nucleic Acids Res (1990) 3.08
Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum (2000) 3.02
Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx Nerve Fiber Analyzer, and Optical Coherence Tomograph. Arch Ophthalmol (2001) 2.99
Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest (1974) 2.96
Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum (1988) 2.93
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Biochemical evidence of thiamine depletion during the Cuban neuropathy epidemic, 1992-1993. Am J Clin Nutr (1996) 2.88
Role of alginate and its O acetylation in formation of Pseudomonas aeruginosa microcolonies and biofilms. J Bacteriol (2001) 2.87
Purchasing for all: an alternative to fundholding. BMJ (1994) 2.86
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Peptide neurotoxins from fish-hunting cone snails. Science (1985) 2.77
Tuberculosis and HIV infection. Lancet (1993) 2.75
'Ending up a GP': a qualitative study of junior doctors' perceptions of general practice as a career. Fam Pract (1997) 2.70
Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ (1993) 2.70
Physical mapping of temperature-sensitive mutations of adenoviruses. J Mol Biol (1975) 2.69
Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol (1989) 2.67
Viral DNA sequences in cells transformed by simian virus 40, adenovirus type 2 and adenovirus type 5. Cold Spring Harb Symp Quant Biol (1975) 2.65
International differences in understanding recovery: systematic review. Epidemiol Psychiatr Sci (2012) 2.57
Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol (1993) 2.56
Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet (1990) 2.52
Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA (1996) 2.50
Susceptibility locus for Alzheimer's disease on chromosome 10. Science (2000) 2.49
Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia (1973) 2.48
Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med (1987) 2.47
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A (1998) 2.46
The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax (1999) 2.45
Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther (1991) 2.44
Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chemother (1997) 2.43
Concurrent validity of the OPCRIT diagnostic system. Comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses. Br J Psychiatry (1996) 2.42
Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety (2001) 2.42
Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study. Arthritis Rheum (1994) 2.41
Reliability of a population survey tool for measuring perceived health problems: a study of patients with osteoarthrosis. J Epidemiol Community Health (1981) 2.38
Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum (1995) 2.38
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Evaluation of the cost of laparoscopic and open cholecystectomy. Br J Surg (1994) 2.37
Voluntary counseling and HIV testing for pregnant women in the Kassena-Nankana district of northern Ghana: is couple counseling the way forward? AIDS Care (2005) 2.36
Mortality rates among wild chimpanzees. J Hum Evol (2001) 2.35
Atmospheric oxidation capacity sustained by a tropical forest. Nature (2008) 2.34
Recruitment and retention of subjects for a longitudinal cancer prevention study in an inner-city black community. Health Serv Res (1995) 2.34
Ambiguous abbreviations: an audit of abbreviations in paediatric note keeping. Arch Dis Child (2007) 2.34
Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol (1985) (1988) 2.34
Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch Dermatol (1992) 2.33
Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet (1992) 2.32
Carcinogenic epoxides of benzo[a]pyrene and cyclopenta[cd]pyrene induce base substitutions via specific transversions. Proc Natl Acad Sci U S A (1982) 2.29
CENTRAL VENOUS PRESSURE IN RELATION TO CARDIAC "COMPETENCE," BLOOD VOLUME AND EXERCISE. J Clin Invest (1946) 2.29
Long-term outcomes of scleroderma renal crisis. Ann Intern Med (2000) 2.27
A full genome scan for late onset Alzheimer's disease. Hum Mol Genet (1999) 2.26
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum (1997) 2.21
Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol (1985) (1988) 2.20
The purification and characterization of arsenite oxidase from Alcaligenes faecalis, a molybdenum-containing hydroxylase. J Biol Chem (1992) 2.20
Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J Invest Dermatol (1999) 2.20
Measurement of fidelity in psychiatric rehabilitation. Ment Health Serv Res (2000) 2.17
Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum (1984) 2.17
Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am Rev Respir Dis (1991) 2.16
Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology (2011) 2.15
Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplantation (1987) 2.14
Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum (1980) 2.13